Trop-2 — Drug Target

All drugs that target Trop-2 — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

antibody-drug conjugate · Monoclonal antibody-drug conjugate

Phase 3 pipeline (1)

• Rescue medications for sacituzumab tirumotecan · Merck Sharp & Dohme LLC · antibody-drug conjugate · Oncology
  Sacituzumab govitecan is an antibody-drug conjugate that targets Trop-2, delivering a cytotoxic payload to cancer cells.

Phase 2 pipeline (1)

• Disitamab Vedotin Injection · RemeGen Co., Ltd. · Monoclonal antibody-drug conjugate · Oncology
  Disitamab vedotin is a monoclonal antibody-drug conjugate that targets the Trop-2 receptor.